Cellceutix Corp. (CTIX) Financials Nov 20, 2014, 4
Post# of 250602
Posted On: 11/20/2014 8:07:43 PM
Cellceutix Corp. (CTIX) Financials Nov 20, 2014, 4:00 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cellceutix Corp.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 975,948 0 - 616 289,000
COGS excluding D&A 975,948 0 - 0 0
Depreciation & Amortization Expense 0 0 0 616 289,000
Depreciation 0 0 0 0 4,000
Amortization of Intangibles 0 0 0 616 285,000
Gross Income (975,948) 0 - (616) (289,000)
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 2.13M 5.72M 4.1M 2.98M 7.75M
Research & Development 2M 1.34M 632,805 1.51M 6.34M
Other SG&A 128,216 4.38M 3.47M 1.47M 1.41M
Other Operating Expense 258,905 0 98,610 0 0
Unusual Expense 0 0 439,892 0 -
EBIT after Unusual Expense 0 0 (439,892) 0 -
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - 0 0 1,000
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 69,335 215,923 257,414 241,462 210,000
Gross Interest Expense 69,335 215,923 257,414 241,462 210,000
Interest Capitalized 0 0 0 0 0
Pretax Income (3.43M) (5.94M) (4.89M) (3.22M) (8.25M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 (1.98M)
Consolidated Net Income (3.43M) (5.94M) (4.89M) (3.22M) (10.23M)
Minority Interest Expense 0 0 0 0 0
Net Income (3.43M) (5.94M) (4.89M) (3.22M) (10.23M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (3.43M) (5.94M) (4.89M) (3.22M) (10.23M)
Preferred Dividends 0 0 65,686 211,802 0
Net Income Available to Common (3.43M) (5.94M) (4.96M) (3.44M) (10.23M)
EPS (Basic) (0.04) (0.07) (0.06) (0.04) (0.10)
Basic Shares Outstanding 91.86M 90.3M 90.16M 94.98M 105.04M
EPS (Diluted) (0.04) (0.07) (0.06) (0.04) (0.10)
Diluted Shares Outstanding 91.86M 90.3M 90.16M 94.98M 105.04M
EBITDA (3.36M) (5.72M) (4.2M) (2.98M) (7.75M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cellceutix Corp.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 975,948 0 - 616 289,000
COGS excluding D&A 975,948 0 - 0 0
Depreciation & Amortization Expense 0 0 0 616 289,000
Depreciation 0 0 0 0 4,000
Amortization of Intangibles 0 0 0 616 285,000
Gross Income (975,948) 0 - (616) (289,000)
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 2.13M 5.72M 4.1M 2.98M 7.75M
Research & Development 2M 1.34M 632,805 1.51M 6.34M
Other SG&A 128,216 4.38M 3.47M 1.47M 1.41M
Other Operating Expense 258,905 0 98,610 0 0
Unusual Expense 0 0 439,892 0 -
EBIT after Unusual Expense 0 0 (439,892) 0 -
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - 0 0 1,000
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 69,335 215,923 257,414 241,462 210,000
Gross Interest Expense 69,335 215,923 257,414 241,462 210,000
Interest Capitalized 0 0 0 0 0
Pretax Income (3.43M) (5.94M) (4.89M) (3.22M) (8.25M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 (1.98M)
Consolidated Net Income (3.43M) (5.94M) (4.89M) (3.22M) (10.23M)
Minority Interest Expense 0 0 0 0 0
Net Income (3.43M) (5.94M) (4.89M) (3.22M) (10.23M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (3.43M) (5.94M) (4.89M) (3.22M) (10.23M)
Preferred Dividends 0 0 65,686 211,802 0
Net Income Available to Common (3.43M) (5.94M) (4.96M) (3.44M) (10.23M)
EPS (Basic) (0.04) (0.07) (0.06) (0.04) (0.10)
Basic Shares Outstanding 91.86M 90.3M 90.16M 94.98M 105.04M
EPS (Diluted) (0.04) (0.07) (0.06) (0.04) (0.10)
Diluted Shares Outstanding 91.86M 90.3M 90.16M 94.98M 105.04M
EBITDA (3.36M) (5.72M) (4.2M) (2.98M) (7.75M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼